Casdin Capital »

Cigna Corp shares owned by Casdin Capital

Quarter-by-quarter ownership of Cigna Corp (CI) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Cigna Corp

Tip: Access up to 7 years of quarterly data

All positions including Cigna Corp held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cigna Corp by Casdin Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 40k 275.23

More positions owned by Casdin Capital

Genedx Holdings Corp Com Cl A (WGS)
Revolution Medicines (RVMD)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Relay Therapeutics (RLAY)
Structure Therapeutics Sponsored Ads (GPCR)
Illumina (ILMN)
Avidity Biosciences Ord (RNA)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Maze Therapeatics (MAZE)
Denali Therapeutics (DNLI)
Alnylam Pharmaceuticals (ALNY)
Neurogene (NGNE)
10x Genomics Cl A Com (TXG)

View all positions for Casdin Capital

Top funds holding Cigna Corp

Vanguard Group
BlackRock
State Street Corporation
Massachusetts Financial Services
Dodge & Cox
FMR
Sanders Capital
GQG Partners
Jpmorgan Chase & Co
Geode Capital Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
Northern Trust
Ameriprise Financial
Invesco

View all funds holding Cigna Corp